| CAR | Chimeric antigen receptor |
| FDA | Food and Drug Administration |
| HPF | Hypothermic preservation formulation |
| DP | Drug product |
| GMP | Good manufacturing practice |
| DMSO | Dimethyl sulfoxide |
| PoC | Point-of-care |
| CQA | Critical quality attribute |
| UW | University of Wisconsin |
| HTK | Histidine-tryptophan-ketoglutarate |
| HTS | HypoThermosol |
| ROS | Reactive oxygen species |
| ATP | Adenosine triphosphate |
| TCA | Tricarboxylic acid |
| NADH | Nicotinamide adenine dinucleotide |
| FADH2 | Flavin adenine dinucleotide |
| RT | Room temperature |
| GGS | Glucose, glutamine, succinate |
| PSU | Pyruvate, uridine, succinate |
| CFS | CliniMACS Formulation Solution |
| TCA | Tricyclic acid |
| HSA | Human serum albumin |
| PI | Propidium iodide |
| ANOVA | Analysis of variance |
| Tcm | Central memory T cell |
| Teff | Effector T cell |
| Tem | Effector memory T cell |
| Tn | Naïve T cell |
| NOAEL | No observed adverse effect level |